Drugs, Data, Deliberations

Total Page:16

File Type:pdf, Size:1020Kb

Drugs, Data, Deliberations JANUARY 2016 Issue 5 [email protected] www.facebook.com/linkagesproject @LINKAGESproject DRUGS, DATA, DELIBERATIONS: PUTTING IT INTO PERSPECTIVE People who inject drugs continue to be disproportionately affected by HIV because of limited investment in — and access to — proven interventions. Even when effective services are available, severe stigma and punitive laws create barriers to their use, compounding people’s risk of acquiring HIV and hepatitis infection through unsterile injection equipment. Discrimination against drug users and criminalization of drug use also make it difficult to collect accurate data about people who inject drugs. Estimates of HIV prevalence among people who inject drugs; the size of drug-using populations; and their use of HIV prevention, care, and treatment services are incomplete, as is understanding of their needs and risk behaviors, because many people are unwilling to identify themselves as users of illicit drugs. All over the world, successful responses Photo Credit: © Malaysian AIDS Council / International HIV/AIDS Alliance to the HIV epidemic have been driven in large part by two key factors: Personal experiences inspired Amran Ismail to establish the first community- political commitment and agency of the based organization in Kuala on the east coast of Malaysia, CAKNA, which constituency group. For people who supports people who inject drugs. inject drugs, neither of these pillars has been given sufficient attention The Link, our guest authors write about of people who inject drugs are often and dedicated focus. In this issue of innovative efforts to strengthen both. gender-neutral or heavily skewed toward the men. Although women who IN THIS ISSUE On page 4, Judy Chang writes about inject drugs are even more hidden than Afghani women who use drugs—a 1 | DRUGS, DATA, DELIBERATIONS their male counterparts, they account 3 | HISTORIES OF COMMUNITY ACTION group who, traditionally, has had about for about one-third of all people who 4 | OUT OF THE SHADOWS as little agency as it’s possible to have. inject drugs.1 5 | DATA AND HUMAN RIGHTS Chang explains how gaps in the data 6 | WHAT WORKS FOR WHOM AND WHERE on these particular women—but also Estimates of those receiving evidence- 7 | IN FOCUS: LINKAGES IN INDIA for all women who inject drugs—are informed and rights-based HIV 8 | THE PEOPLE @ LINKAGES particularly pronounced. National and and harm reduction services are 9 | NEW RESOURCES international research and surveillance ARTICLE CONTINUED ON PAGE 2 DRUGS, DATA, DELIBERATIONS: PUTTING IT INTO PERSPECTIVE CoNtINued froM PAge 1 also problematic, but coverage is HIV. In addition to more comprehensive to guide the programs that serve undoubtedly poor. Fewer than eight data, he writes, we need a better them. Implementing Comprehensive in 100 people who inject drugs have understanding of how to promote HIV and STI Programmes with People access to opioid substitution therapy application of the data we have. Who Inject Drugs: Practical Guidance (OST), and only an average of two sterile for Collaborative Interventions, to be needles are distributed per month per However, a number of promising published in 2016, will be a welcome person who injects drugs.2 HIV-positive developments suggest a potential trend resource for improving programs. people who inject drugs appear to toward more evidence-based policies have lower rates of HIV treatment and and greater political commitment. In It’s true that more information is viral suppression compared to other April 2016, The UN General Assembly needed to better understand the most key populations, in part because many will hold a Special Session (UNGASS) effective way to provide services for people do not report their drug use on drugs. This Special Session will offer people who inject drugs and to retain when they seek these services.3 member states the opportunity to them in the HIV care cascade. But, put deliberate on the thorny issues related into perspective, data are just one part Estimating coverage may be to drug law reform. For over a year, of a bigger picture. In the absence of challenging, but the evidence base for organizations led by people who inject perfect data, governments must be comprehensive HIV and harm reduction drugs as well as other stakeholders determined to move from deliberation services for people who inject drugs have been participating in pre-UNGASS to action. The history of response to the AIDS epidemic was built through this combination of data and resolve and Fewer than eight in 100 people who inject drugs have based on the fundamental principles of access to opioid substitution therapy (OST), and only an people-centered approaches. average of two sterile needles are distributed per month 1. Degenhardt L, Whiteford HA, Ferrari AJ, et al. Global burden of disease attributable per person who injects drugs. to illicit drug use and dependence: find- ings from the Global Burden of Disease Study 2010. Lancet. 2013;382(9904):1564- is strong. Distributing free or low-cost consultations to share their practical 74. Available from: http://www.thelancet. com/journals/lancet/article/PIIS0140- sterile needles reduces HIV transmission expertise and experiences. 6736(13)61530-5/abstract. http://www. among people who inject drugs without thelancet.com/pdfs/journals/lancet/ increasing drug use, and it is most Most recently, the U.S. Congress PIIS0140-6736(13)61530-5.pdf. effectively lifted a decades-long ban on effective when combined with access to 2. UNAIDS. People who inject drugs. In: needle and syringe programs. Malaysia OST and HIV counseling and treatment. The gap report. Geneva, Switzerland: OST reduces high-risk injection has transformed eight compulsory UNAIDS; 2014. Available from: http:// behaviors and drug-related deaths while detention centers into voluntary care www.unaids.org/en/resources/cam- improving adherence to antiretroviral clinics and has expanded OST provision paigns/2014/2014gapreport/gapreport. regimens among HIV-positive people in prisons. Tanzania has established the 3. Pierce R, Hegle J, Sabin K, et al. Strategic who inject drugs.4 first community-based OST program in information is everyone’s business: per- East Africa. spectives from an international stake- holder meeting to enhance strategic Despite the strength of this evidence, information data along the HIV cascade Such community action has been most countries continue to emphasize for people who inject drugs. Harm Re- criminalization over harm reduction. instrumental in the development of duct J. 2015;12:41. Available from: http:// Drug use is illegal in all but a handful of harm reduction, writes Andy Guise on harmreductionjournal.biomedcentral. countries, and few offer harm reduction page 3. His call for research on how to com/articles/10.1186/s12954-015-0073-y. services in prisons. In many countries, support community action and a study 4. WHO, UNODC. UNAIDS technical guide people who inject drugs experience exploring how to support integrated for countries to set targets for universal involuntary drug testing and compulsory OST and HIV care in Kenya (see access to HIV prevention, treatment and care for injecting drug users – 2012 revi- page 6) are examples of a much-needed detention, or “rehabilitation,” which sion. Geneva, Switzerland: WHO; 2012. rarely includes OST. implementation science approach Available from: http://www.who.int/hiv/ to adapting proven interventions for pub/idu/targets_universal_access/en/. Lack of commitment is one cause of the people who inject drugs in different Photofailure Credit: to heed © evidence,Steve Lambert as Ralf Jürgens settings. notes in his article on page 5. This, rather than the scarcity or quality of data, is A central theme of this issue of The the main reason why people who inject Link is the importance of engaging drugs are left behind in the response to people who inject drugs in research 2 LEARNING FROM HISTORIES OF COMMUNITY ACTION In New York in the late 1970s and early research and development of biomedical Community action, and how to support it, 1980s, before the public health and med- methods of HIV prevention, and just 1% is then a key priority for global health re- ical authorities had recognized HIV and of that is oriented toward their social and search in the response to HIV for, and with, taken action, people who were injecting behavioral dimensions.5 New HIV research people who use drugs. Among the many drugs responded to the new challenge priorities from within the NIH’s Office of issues to learn about: facing them. Even hostile policing couldn’t AIDS Research also focus almost exclu- • The various roles people who use drugs 6 stop the emergence of a market in sterile sively on cure and treatment efforts. can play in facilitating access to care needles and syringes among the drug us- Biomedical interventions for people who within clinics ing community to replace the home-made use drugs are, of course, essential. PrEP, • How community action can foster new and frequently shared injecting equipment vaccines, and microbicides should all form norms that support preventive action that was being linked to HIV.1 part of a comprehensive HIV strategy, and that allow for the uptake of new This is just one vignette, from a specific alongside ART, opioid substitution thera- biomedical interventions time and place, but stories like this one pies, and needle and syringe programs. • How people who use drugs, and their have occurred many, many times around Community mobilization is in turn networks, are instrumental in altering the world. People who use drugs have been essential to ensure the relevance of these the structural environment and over- 7 central to the development of HIV and interventions and their accessibility. coming barriers, such as police brutality, harm reduction services, in settings from And yet, community mobilization, espe- that create vulnerability to HIV 1, 2 Africa and Asia to Europe and America.
Recommended publications
  • Communications Handbook for Clinical Trials
    Communications Handbook for Clinical Trials Strategies, tips, and tools to manage controversy, convey your message, and disseminate results By Elizabeth T. Robinson Deborah Baron Lori L. Heise Jill Moffett Sarah V. Harlan Preface by Archbishop Desmond M. Tutu Communications Handbook for Clinical Trials Strategies, tips, and tools to manage controversy, convey your message, and disseminate results By Elizabeth T. Robinson Deborah Baron Lori L. Heise Jill Moffett Sarah V. Harlan Preface by Archbishop Desmond M. Tutu Communications Handbook for Clinical Trials: Strategies, Tips, and Tools to Manage Controversy, Convey Your Message, and Disseminate Results Authors: Elizabeth T. Robinson, Deborah Baron, Lori L. Heise, Jill Moffett, Sarah V. Harlan © FHI 360 ISBN: 1-933702-57-5 The handbook is co-published by the Microbicides Media and Communications Initiative, a multi-partner collaboration housed at the Global Campaign for Microbicides at PATH in Washington, DC, and by Family Health International in Research Triangle Park, NC, USA. In July 2011, FHI became FHI 360. The Microbicides Media and Communica- tions Initiative is now housed at AVAC. AVAC: Global Advocacy for HIV Prevention 423 West 127th Street, 4th Floor New York, NY 10027 USA Tel: +1.212.796.6243 Email: [email protected] Web: www.avac.org FHI 360 P.O. Box 13950 Research Triangle Park, NC 27709 USA Tel: +1.919.544.7040 E-mail: [email protected] Web: www.fhi360.org This work was made possible by the generous support of the American people through the U.S. Agency for International Development (USAID) through dual grants to the Microbicides Media and Communications Initiative (MMCI), a project of the Global Campaign for Microbicides at PATH, and to FHI 360.
    [Show full text]
  • Fhi-360-Impact-Report-2019.Pdf
    2019 Contents Impact Stories � � � � � � � � � � � � � � � � � � � � � � � � � � � � 2 Financial Summary � � � � � � � � � � � � � � � � � � � � � � � 14 Funders � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � 17 Global Reach � � � � � � � � � � � � � � � � � � � � � � � � � � � � � 19 Contact Us � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � 20 FHI 360 2019 IMPACT REPORT 1 CRISIS RESPONSE Responding in real time to Ebola PROJECT Rapid response and building trust with DRC Ebola Rapid Response communities are critical when stopping the spread of infectious disease� During the 2018 FUNDER Ebola outbreak in the Democratic Republic of U�S� Agency for the Congo, we worked with hundreds of International Development, Office of U�S� Foreign community leaders who mobilized their Disaster Assistance communities in prevention, surveillance and control of the disease� Local teams were trained to conduct safe and dignified burials for Ebola victims with the consent of families and communities and responded to 672 community death alerts in North Kivu and Ituri provinces� Our Ebola community engagement activities reached more than 9,000 people, including 679 community leaders in provinces most 9,000+ affected by the outbreak� people reached through community engagement activities in the Democratic Republic of the Congo FHI 360 2019 IMPACT REPORT 2 EDUCATION Building community among Native American tribes PROJECT Across the United States, less than 2 percent Head Start of the 46,000 Native American and Alaskan Native children
    [Show full text]
  • Vitalconnections
    2012 annuAL REPORT vitalconnections www.fhi360.org LETTER FROM THE CEO Adolescent girls in Kenya are paired with In FHI 360’s 2012 annual report, you will older mentors who encourage them to read about just a few of the connections that further their education. distinguish our unique ability to bring a 360° perspective to some of the world’s most Mothers in Vietnam are supported to give complex human development challenges. infants the best start in life through landmark And you will see how we translate this legislation and promotion of breastfeeding perspective into customized solutions that best practices. are making a real difference in people’s lives around the world. Researchers from around the world bring “Making the right together experience and skills to develop Ensuring our work is relevant and leads to the next generation of family planning sustainable results guides our every step. technologies. Informed by sound evidence and decades of connections can collaborative in-country experience, we design Making the right connections can our programs and initiatives to strengthen the transform lives. capacity of communities and nations to solve transform lives.” problems and drive progress for years to come. This past year, we connected as never before. Our reach was global; our impact, lasting. Ours is a journey of collaboration where our Our experts in health, education, nutrition, funders and partners are at the heart of all environment, economic development, we do. Through these most vital connections civil society, gender equality, youth, we can see farther, dream bigger and achieve research, technology, communication and far more than we ever could alone.
    [Show full text]
  • Biobehavioural Survey Guidelines for Populations at Risk for HIV © World Health Organization 2017
    Global HIV Strategic Information Working Group Biobehavioural Survey Guidelines For Populations At Risk For HIV © World Health Organization 2017 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo). The mark “CDC” is owned by the US Dept. of Health and Human Services and is used with permission. Use of this logo is not an endorsement by HHS or CDC of any particular product, service, or enterprise. Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”. Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization. Suggested citation WHO, CDC, UNAIDS, FHI 360. Biobehavioral survey guidelines for Populations at Risk for HIV.
    [Show full text]
  • Programme INTEREST 2020
    PROGRAMME BOOK www.interestconference.org Table of Contents Welcome 3 Objectives 4 Practical Information 5 Time Zones 6 Committees 8 Programme 13 Acknowledgement 24 2 INTEREST 2020 - Programme Book Welcome Dear Colleagues, Welcome to the 14th INTEREST Conference November 30-December 4, 2020 and the conference pre-week November 23-27! Since 2014, we have dedicated the annual INTEREST Conference to the memory of Professor Joep Lange and Jacqueline van Tongeren of the Amsterdam Institute for Global Health and Development. Pivotal in establishing the INTEREST conference as a leading African and international forum for the dissemination of HIV science and practice, they died tragically when Malaysian Airlines flight MH17 was shot down over Ukraine on July 17, 2014. The INTEREST Conference is now a recognised fixture in the HIV conference calendar. It focuses on HIV treatment, pathogenesis, and prevention in resource-limited settings, particularly in Africa. Young researchers and established international HIV experts share original research and state-of-the-art reviews on a wide range of HIV and related topics. In light of the SARS-CoV-2 pandemic, the 14th INTEREST conference was initially postponed from the face-to-face conference that had been planned for Windhoek, Namibia in May to the first week of December. A decision was made in late August 2020 to move to a virtual format, which has proven to be a wise move, given that the pandemic is continuing to expand as INTEREST pre-week activities are about to start. The 14th INTEREST conference offers lectures, abstract-driven oral and poster sessions, and symposia but this year there will be no debates or meet-the-expert lunches.
    [Show full text]
  • Strategic Considerations for Strengthening the Linkages Between Family Planning and HIV/AIDS Policies, Programs, and Services
    Family Planning HIV/AIDS Strategic Considerations for Strengthening the Linkages between Family Planning and HIV/AIDS Policies, Programs, and Services In July 2011, FHI became FHI 360. FHI 360 is a nonprofit human development organization dedicated to improving lives in lasting ways by advancing integrated, locally driven solutions. Our staff includes experts in health, education, nutrition, environment, economic development, civil society, gender, youth, research and technology – creating a unique mix of capabilities to address today’s interrelated development challenges. FHI 360 serves more than 60 countries, all 50 U.S. states and all U.S. territories. Visit us at www.fhi360.org. Family Planning HIV/AIDS Strategic Considerations for Strengthening the Linkages between Family Planning and HIV/AIDS Policies, Programs, and Services Strategic Considerations for Strengthening the Linkages between Family Planning and HIV/AIDS Policies, Programs, and Services © 2009 by World Health Organization All rights reserved. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 3264; fax: +41 22 791 4857; e-mail: [email protected]). Requests for permission to reproduce or translate WHO publications—whether for sale or for noncommercial distribution—should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; e-mail: [email protected]). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.
    [Show full text]
  • Copyright and Use of This Thesis This Thesis Must Be Used in Accordance with the Provisions of the Copyright Act 1968
    COPYRIGHT AND USE OF THIS THESIS This thesis must be used in accordance with the provisions of the Copyright Act 1968. Reproduction of material protected by copyright may be an infringement of copyright and copyright owners may be entitled to take legal action against persons who infringe their copyright. Section 51 (2) of the Copyright Act permits an authorized officer of a university library or archives to provide a copy (by communication or otherwise) of an unpublished thesis kept in the library or archives, to a person who satisfies the authorized officer that he or she requires the reproduction for the purposes of research or study. The Copyright Act grants the creator of a work a number of moral rights, specifically the right of attribution, the right against false attribution and the right of integrity. You may infringe the author’s moral rights if you: - fail to acknowledge the author of this thesis if you quote sections from the work - attribute this thesis to another author - subject this thesis to derogatory treatment which may prejudice the author’s reputation For further information contact the University’s Director of Copyright Services sydney.edu.au/copyright Good, better or best: A study of standards of prevention and care in HIV prevention trials Bridget Haire A thesis submitted in fulfilment of the requirements for the degree of DOCTOR OF PHILOSOPHY at the University of Sydney, Sydney, New South Wales, Australia. 2013 Supervisor’s Certification I, Dr Christopher Jordens, certify that the PhD thesis entitled ‘Good, better or best: A study of standards of prevention and care in HIV prevention trials’ by Bridget Haire is in a suitable form for examination.
    [Show full text]
  • Health System Rapid Diagnostic Tool
    VersION 1 Health System Rapid Diagnostic Tool FRAMEWORK, OPERATIONAL GUIDE, AND METRICS TO MEASURE THE STRENGTH OF PRIORITY HEALTH SYSTEM FUNCTIONS By David Wendt With contributions from Bruno Bouchet, Ya-Shin Lin, Lipika Nanda, Shanthi Noriega, Nilufar Rakhmanova, and Sarah Searle PREPARING FOR THE RAPID DIAGNOSTIC I TABLE OF CONTENTS Foreword.......................................................................................................... 2 Annex 1: Selected References ................................... 39 Abbreviations ................................................................................................. 3 Annex 2: FHI 360 Health System Framework ....... 41 Annex 3: Rapid Diagnostic Project Participants . 42 1. Introduction ................................................................................................ 4 Annex 4: Self-Assessment Form .............................. 43 2. Detailed Guidance on the Steps ........................................................... 8 Annex 5: Common Sources for Data ....................... 44 PHASE I: PREPARING FOR THE RAPID DIAGNOSTIC ................ 9 Annex 6: Performance Metrics Table Template .. 48 Step 1) Draft the purpose and scope of the diagnostic .... 9 Annex 7: Kenya’s Indicator Dashboard ................... 49 Step 2) Gain buy-in and recruit partners ............................. 10 Annex 8: Methods for Prioritizing Ideas ................. 51 Step 3) Recruit a core team ..................................................... 10 Annex 9: Illustrative Collection
    [Show full text]